- SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. Rinaldi-Carmona, M., Barth, F., Millan, J., Derocq, J.M., Casellas, P., Congy, C., Oustric, D., Sarran, M., Bouaboula, M., Calandra, B., Portier, M., Shire, D., Brelière, J.C., Le Fur, G.L. J. Pharmacol. Exp. Ther. (1998)